In addition, the MUC1 inhibitory peptide, PMIP, that contains the β-catenin/p120-catenin binding motif present in the MUC1-CT, blocked CS-induced interaction between MUC1-CT and p120-catenin, thus stabilizing adherens junctions and decreasing cancer progression [116,120]. The gene discussed is MUC1; the disease is cancer.